Tohoku University
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1907-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.tohoku.ac.jp
Clinical Trials
400
Active:0
Completed:192
Trial Phases
4 Phases
Phase 1:7
Phase 2:7
Phase 3:4
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (397 trials with phase data)• Click on a phase to view related trials
Not Applicable
379 (95.5%)Phase 1
7 (1.8%)Phase 2
7 (1.8%)Phase 3
4 (1.0%)Evaluation of Effectiveness and Safety of Xa Inhibitor for the Prevention of Stroke And Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-valvular Atrial Fibrillation
- Conditions
- Non-valvular Atrial Fibrillation
- First Posted Date
- 2014-05-26
- Last Posted Date
- 2014-05-26
- Lead Sponsor
- Tohoku University
- Target Recruit Count
- 7000
- Registration Number
- NCT02147444
- Locations
- 🇯🇵
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
Amnesia After Surgery for Anterior Communicating Aneurysm： High Resolution Magnetic Resonance (MR) Imaging Findings
Completed
- Conditions
- Subarachnoid HemorrhageCerebral AneurysmAmnesia
- First Posted Date
- 2013-08-09
- Last Posted Date
- 2013-08-09
- Lead Sponsor
- Tohoku University
- Target Recruit Count
- 14
- Registration Number
- NCT01919775
Pharmacokinetic Study on N-acetylneuraminic Acid
Phase 1
Completed
- Conditions
- Nonaka MyopathyHereditary Inclusion Body Myopathy
- Interventions
- First Posted Date
- 2010-11-09
- Last Posted Date
- 2011-09-08
- Lead Sponsor
- Tohoku University
- Target Recruit Count
- 6
- Registration Number
- NCT01236898
- Locations
- 🇯🇵
Tohoku University Hospital, Sendai, Miyagi, Japan
Vitamin D Supplementation Prevents Elderly Pneumonia
Not Applicable
Completed
- Conditions
- Bacterial Pneumonia
- First Posted Date
- 2009-04-07
- Last Posted Date
- 2009-04-08
- Lead Sponsor
- Tohoku University
- Target Recruit Count
- 100
- Registration Number
- NCT00877422
- Locations
- 🇯🇵
Institute of Development, Aging and Cancer, Tohoku University, 1-1,Seiryo-machi,Aoba-ku,Sendai, Japan
Effect of Bifidobacterium on Irritable Bowel Syndrome
Not Applicable
- Conditions
- Irritable Bowel Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-08-20
- Last Posted Date
- 2008-08-20
- Lead Sponsor
- Tohoku University
- Target Recruit Count
- 50
- Registration Number
- NCT00737841
- Locations
- 🇯🇵
Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
- Prev
- 1
- 2
- Next
News
First Oral Drug MA-5 Shows Promise for Rare Barth Syndrome in Preclinical Studies
Researchers at Tohoku University discovered that oral drug MA-5 can improve both heart and muscle problems in Barth syndrome, a rare genetic disorder affecting 1 in 300,000 births worldwide.